IE
BNTX icon

Israel Englander’s BioNTech BNTX Stock Holding History

Israel Englander’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,372
Closed -$3.33M – 5888
2026
Q1 		$3.14M Sell
35,372
-236,993
-87% -$24.4M ﹤0.01% 3430
2025
Q4 		$25.9M Buy
272,365
+26,038
+11% +$2.62M 0.01% 1325
2025
Q3 		$24.3M Buy
+246,327
New +$26.3M 0.01% 1465
2025
Q2 		– Sell
-544,970
Closed -$55M – 5876
2025
Q1 		$49.6M Buy
544,970
+373,660
+218% +$41.8M 0.03% 775
2024
Q4 		$19.5M Buy
171,310
+147,215
+611% +$16.8M 0.01% 1544
2024
Q3 		$2.86M Sell
24,095
-630,021
-96% -$57.9M ﹤0.01% 3359
2024
Q2 		$52.6M Buy
654,116
+466,472
+249% +$42.6M 0.02% 759
2024
Q1 		$17.3M Buy
187,644
+21,691
+13% +$2.08M 0.01% 1680
2023
Q4 		$17.5M Sell
165,953
-332,448
-67% -$33.5M 0.01% 1649
2023
Q3 		$54.1M Buy
498,401
+147,391
+42% +$16.3M 0.03% 652
2023
Q2 		$37.9M Sell
351,010
-119,866
-25% -$13.5M 0.02% 922
2023
Q1 		$58.7M Buy
470,876
+348,853
+286% +$47.9M 0.03% 597
2022
Q4 		$18.3M Buy
122,023
+35,738
+41% +$5.5M 0.01% 1527
2022
Q3 		$11.6M Sell
86,285
-330,028
-79% -$50.5M 0.01% 1947
2022
Q2 		$62.1M Buy
416,313
+154,877
+59% +$23.7M 0.04% 527
2022
Q1 		$44.6M Buy
261,436
+240,607
+1,155% +$40.4M 0.02% 762
2021
Q4 		$5.37M Sell
20,829
-289,001
-93% -$79.2M ﹤0.01% 2831
2021
Q3 		$84.6M Buy
309,830
+73,611
+31% +$23.4M 0.05% 383
2021
Q2 		$52.9M Buy
236,219
+143,690
+155% +$27.1M 0.03% 575
2021
Q1 		$10.1M Sell
92,529
-96,537
-51% -$10.3M 0.01% 1758
2020
Q4 		$15.4M Sell
189,066
-78,664
-29% -$7.72M 0.01% 1291
2020
Q3 		$18.5K Buy
267,730
+99,632
+59% +$7.15M 0.02% 838
2020
Q2 		$11.2M Buy
168,098
+160,425
+2,091% +$8.01M 0.02% 1136
2020
Q1 		$448K Sell
7,673
-132,532
-95% -$5.16M ﹤0.01% 2958
2019
Q4 		$4.75M Buy
+140,205
New +$3.14M 0.01% 1980

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Israel Englander's BNTX Position: Q2 2026 in Review

Israel Englander sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 35,372 shares — an estimated $3.33M sold.

Israel Englander first reported a position in BNTX in Q4 2019 and held it in 25 quarters. The position peaked at $84.6M in Q3 2021. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Israel Englander reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 35,372 BioNTech shares in Q2 2026, an estimated $3.33M.
  • Israel Englander first reported a position in BioNTech in Q4 2019 and held it in 25 quarters.
  • Israel Englander's BioNTech position peaked at $84.6M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.